Vistin Pharma ASA (VISTN)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 18.20 |
|---|---|
| 52-week range | 17.70 – 23.50 |
| Return, 1 month / 3 months | −0.3% / −10.3% |
| Return, 1 year / 3 years | −14.2% / −6.2% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 24.3% |
| Worst drawdown (1 year) | -18.8% |
| Average daily value traded | 0.23M NOK |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Vistin Pharma ASA (VISTN) trades on the Oslo Børs in Norway. It last closed at NOK 18.20 on 27 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 193 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.2% and over the last three months it fell 10.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.5% | ||
| From 52-week high | -21.6% | ||
| Momentum | 26 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.3% | ||
| 6-month return | -16.1% | ||
| 12-month return, skipping the last month | -14.0% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.8% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.23M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 35 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −0.3% |
| 3 months | −10.3% |
| 6 months | −16.1% |
| 1 year | −14.2% |
| 3 years | −6.2% |
| 5 years | +5.2% |
Signals
| 50-day / 200-day average | 18.63 / 20.10 |
|---|---|
| Golden / death cross (60 days) | Death, 53 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | NOK 1.0000 |
| 4 Jun 2025 | NOK 1.2500 |
| 6 Nov 2024 | NOK 0.5000 |
| 5 Jun 2024 | NOK 0.5000 |
| 23 Jan 2024 | NOK 0.7500 |
| 21 May 2021 | NOK 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.